FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1750499427> ?p ?o ?g. }

• W1750499427 endingPage "20150388" @default.
• W1750499427 startingPage "20150388" @default.
• W1750499427 abstract "Recently, two phase III studies of bevacizumab, an anti-angiogenic, for newly diagnosed glioblastoma (GBM) patients were released. While they were unable to statistically significantly demonstrate that bevacizumab in combination with other therapies increases the overall survival of GBM patients, there remains a question of potential benefits for subpopulations of patients. We use a mathematical model of GBM growth to investigate differential benefits of combining surgical resection, radiation and bevacizumab across observed tumour growth kinetics. The differential hypoxic burden after gross total resection (GTR) was assessed along with the change in radiation cell kill from bevacizumab-induced tissue re-normalization when starting therapy for tumours at different diagnostic sizes. Depending on the tumour size at the time of treatment, our model predicted that GTR would remove a variable portion of the hypoxic burden ranging from 11% to 99.99%. Further, our model predicted that the combination of bevacizumab with radiation resulted in an additional cell kill ranging from 2.6×10(7) to 1.1×10(10) cells. By considering the outcomes given individual tumour kinetics, our results indicate that the subpopulation of patients who would receive the greatest benefit from bevacizumab and radiation combination therapy are those with large, aggressive tumours and who are not eligible for GTR." @default.
• W1750499427 created "2016-06-24" @default.
• W1750499427 creator A5010725891 @default.
• W1750499427 creator A5014011778 @default.
• W1750499427 creator A5052721598 @default.
• W1750499427 creator A5057210157 @default.
• W1750499427 creator A5069870901 @default.
• W1750499427 creator A5073998569 @default.
• W1750499427 date "2015-08-01" @default.
• W1750499427 modified "2023-10-17" @default.
• W1750499427 title "In silico analysis suggests differential response to bevacizumab and radiation combination therapy in newly diagnosed glioblastoma" @default.
• W1750499427 cites W1529490909 @default.
• W1750499427 cites W1978041336 @default.
• W1750499427 cites W1978139448 @default.
• W1750499427 cites W1984710632 @default.
• W1750499427 cites W1987846933 @default.
• W1750499427 cites W1988109237 @default.
• W1750499427 cites W1994230764 @default.
• W1750499427 cites W1997542574 @default.
• W1750499427 cites W2002727873 @default.
• W1750499427 cites W2003857914 @default.
• W1750499427 cites W2006202974 @default.
• W1750499427 cites W2012255417 @default.
• W1750499427 cites W2024080420 @default.
• W1750499427 cites W2030017300 @default.
• W1750499427 cites W2035527703 @default.
• W1750499427 cites W2046122656 @default.
• W1750499427 cites W2057546462 @default.
• W1750499427 cites W2061361188 @default.
• W1750499427 cites W2096287682 @default.
• W1750499427 cites W2101332957 @default.
• W1750499427 cites W2106977499 @default.
• W1750499427 cites W2111967308 @default.
• W1750499427 cites W2112130807 @default.
• W1750499427 cites W2113128467 @default.
• W1750499427 cites W2117692326 @default.
• W1750499427 cites W2124736921 @default.
• W1750499427 cites W2127745545 @default.
• W1750499427 cites W2137686302 @default.
• W1750499427 cites W2139899744 @default.
• W1750499427 cites W2154169182 @default.
• W1750499427 cites W2156330848 @default.
• W1750499427 cites W2157500906 @default.
• W1750499427 cites W2160645528 @default.
• W1750499427 cites W3141585456 @default.
• W1750499427 doi "https://doi.org/10.1098/rsif.2015.0388" @default.
• W1750499427 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4535409" @default.
• W1750499427 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26202682" @default.
• W1750499427 hasPublicationYear "2015" @default.
• W1750499427 type Work @default.
• W1750499427 sameAs 1750499427 @default.
• W1750499427 citedByCount "13" @default.
• W1750499427 countsByYear W17504994272016 @default.
• W1750499427 countsByYear W17504994272017 @default.
• W1750499427 countsByYear W17504994272018 @default.
• W1750499427 countsByYear W17504994272019 @default.
• W1750499427 countsByYear W17504994272020 @default.
• W1750499427 countsByYear W17504994272021 @default.
• W1750499427 countsByYear W17504994272022 @default.
• W1750499427 countsByYear W17504994272023 @default.
• W1750499427 crossrefType "journal-article" @default.
• W1750499427 hasAuthorship W1750499427A5010725891 @default.
• W1750499427 hasAuthorship W1750499427A5014011778 @default.
• W1750499427 hasAuthorship W1750499427A5052721598 @default.
• W1750499427 hasAuthorship W1750499427A5057210157 @default.
• W1750499427 hasAuthorship W1750499427A5069870901 @default.
• W1750499427 hasAuthorship W1750499427A5073998569 @default.
• W1750499427 hasBestOaLocation W17504994271 @default.
• W1750499427 hasConcept C126322002 @default.
• W1750499427 hasConcept C143998085 @default.
• W1750499427 hasConcept C2776194525 @default.
• W1750499427 hasConcept C2776694085 @default.
• W1750499427 hasConcept C2776999253 @default.
• W1750499427 hasConcept C2777802072 @default.
• W1750499427 hasConcept C502942594 @default.
• W1750499427 hasConcept C509974204 @default.
• W1750499427 hasConcept C71924100 @default.
• W1750499427 hasConceptScore W1750499427C126322002 @default.
• W1750499427 hasConceptScore W1750499427C143998085 @default.
• W1750499427 hasConceptScore W1750499427C2776194525 @default.
• W1750499427 hasConceptScore W1750499427C2776694085 @default.
• W1750499427 hasConceptScore W1750499427C2776999253 @default.
• W1750499427 hasConceptScore W1750499427C2777802072 @default.
• W1750499427 hasConceptScore W1750499427C502942594 @default.
• W1750499427 hasConceptScore W1750499427C509974204 @default.
• W1750499427 hasConceptScore W1750499427C71924100 @default.
• W1750499427 hasIssue "109" @default.
• W1750499427 hasLocation W17504994271 @default.
• W1750499427 hasLocation W17504994272 @default.
• W1750499427 hasLocation W17504994273 @default.
• W1750499427 hasLocation W17504994274 @default.
• W1750499427 hasOpenAccess W1750499427 @default.
• W1750499427 hasPrimaryLocation W17504994271 @default.
• W1750499427 hasRelatedWork W2087736549 @default.
• W1750499427 hasRelatedWork W2094410967 @default.
• W1750499427 hasRelatedWork W2123323025 @default.
• W1750499427 hasRelatedWork W2129608087 @default.
• W1750499427 hasRelatedWork W2159303174 @default.

• next